Caplin Point Laboratories zooms on reporting 21% rise in Q1 consolidated net profit
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Caplin Point Laboratories is currently trading at Rs. 998.00, up by 101.55 points or 11.33% from its previous closing of Rs. 896.45 on the BSE.
The scrip opened at Rs. 896.45 and has touched a high and low of Rs. 1008.55 and Rs. 896.00 respectively. So far 151365 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1008.55 on 08-Aug-2023 and a 52 week low of Rs. 575.00 on 29-Mar-2023.
Last one week high and low of the scrip stood at Rs. 1008.55 and Rs. 878.20 respectively. The current market cap of the company is Rs. 7406.96 crore.
The promoters holding in the company stood at 70.63%, while Institutions and Non-Institutions held 2.95% and 26.42% respectively.
Caplin Point Laboratories has reported 20.60% rise in its net profit at Rs 76.27 crore for the first quarter ended June 30, 2023 as compared to Rs 63.24 crore for the same quarter in the previous year. Total income of the company increased by 32.75% at Rs 200.93 crore for Q1FY24 as compared Rs 151.36 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 20.76% rise in net profit at Rs 104.23 crore for the first quarter ended June 30, 2023 as compared to Rs 86.31 crore for the same quarter in the previous year. Total income of the company increased by 13.07% at Rs 407.36 crore for Q1FY24 as compared Rs 360.27 crore for the corresponding quarter previous year.
